Roger M Perlmutter has an estimated net worth of $99.2 Million. This is based on reported shares across multiple companies, which include Merck & Co., Inc., NGM BIOPHARMACEUTICALS INC, AMGEN INC, STEMCELLS INC, and Eikon Therapeutics, Inc..
2009 was Roger M Perlmutter's most active year for acquiring shares with 6 total transactions. Roger M Perlmutter's most active month to acquire stocks was the month of April. 2005 was Roger M Perlmutter's most active year for disposing of shares, totalling 95 transactions. Roger M Perlmutter's most active month to dispose stocks was the month of October. 2018 saw Roger M Perlmutter paying a total of $12,051,850.46 for 406,757 shares, this is the most they've acquired in one year. In 2018 Roger M Perlmutter cashed out on 450,886 shares for a total of $16,967,967.39, their largest year based on trade value.